INTERNATIONAL PATENT: DAEWOONG PHARMACEUTICAL CO., LTD., 주식회사 대웅제약 FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITION COMPRISING ENAVOGLIFLOZIN AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING ALOPECIA AREATA"

GENEVA, July 9 -- DAEWOONG PHARMACEUTICAL CO., LTD. (35-14, Jeyakgongdan 4-gil,Hyangnam-eupHwaseong-siGyeonggi-do 18623), 주식회사 대웅제약 (경기도화성시향남읍 제약공단4길 35-14) filed a patent application (PCT/KR2024/021275) for "PHARMACEUTICAL COMPOSITION COMPRISING ENAVOGLIFLOZIN AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING ALOPECIA AREATA" on Dec 27, 2024. With publication no. WO/2025/143870, the details related to the patent application was published on Jul 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World I...